Helmberger T, Mergo P J, Stoupis C, Torres G M, Burton S S, Ros P R
Department of Radiology, University of Florida College of Medicine, Gainesville 32610, USA.
J Comput Assist Tomogr. 1998 May-Jun;22(3):391-7. doi: 10.1097/00004728-199805000-00009.
Our goal was to determine the efficacy of a dedicated protocol for pancreatic MRI using fat suppression, oblique plane orientation, and barium as an oral contrast agent.
Fifty-two patients were enrolled in our study. In each patient, the stomach and duodenum were opacified with 300 ml oral barium. In all patients conventional SE T1- and T2-weighted images and fat-suppressed axial and oblique T1-weighted images of the upper abdomen and the pancreas, respectively, were obtained. The different T1-weighted sequences were compared for visualization of the pancreas and for lesion conspicuity. Oblique images were obtained in a plane parallel to the overall axis of the pancreas. All sequences were qualitatively assessed by two independent blinded readers and statistically compared.
The combination of fat suppression and oblique imaging significantly improved the visualization of the different anatomic portions of the normal pancreas as well as pathologic findings in the pancreas in 70-92% of the cases compared with conventional axial T1-weighted imaging (p < 0.001) and in 52-75% of the cases compared with axial fat-suppressed T1-weighted imaging (p < 0.001), respectively. Increased image noise and blurring artifacts resulted in slight image degradation after Gd-DTPA administration. Barium as a duodenal contrast agent was beneficial for delineation of the pancreatic head from the adjacent bowel structures.
In pancreatic imaging, fat-suppressed T1-weighted imaging is superior to conventional T1-weighted imaging, and oblique imaging is superior to axial imaging. Intravenous Gd-DTPA administration was useful only in selected cases.
我们的目标是确定一种专门的胰腺磁共振成像(MRI)方案的有效性,该方案使用脂肪抑制、斜平面定位以及钡剂作为口服对比剂。
52名患者纳入我们的研究。每位患者口服300毫升钡剂使胃和十二指肠显影。所有患者均分别获取上腹部和胰腺的常规自旋回波(SE)T1加权和T2加权图像以及脂肪抑制的轴位和斜位T1加权图像。比较不同的T1加权序列对胰腺的显示情况以及病变的清晰度。在与胰腺整体轴线平行的平面上获取斜位图像。所有序列由两名独立的不知情阅片者进行定性评估并进行统计学比较。
与传统轴位T1加权成像相比,脂肪抑制和斜位成像相结合在70% - 92%的病例中显著改善了正常胰腺不同解剖部位的显示以及胰腺病理表现的显示(p < 0.001);与轴位脂肪抑制T1加权成像相比,分别在52% - 75%的病例中显著改善了显示情况(p < 0.001)。注射钆喷替酸葡甲胺(Gd - DTPA)后,图像噪声增加和模糊伪影导致图像略有退化。钡剂作为十二指肠对比剂有助于将胰头与相邻肠结构区分开来。
在胰腺成像中,脂肪抑制T1加权成像优于传统T1加权成像,斜位成像优于轴位成像。静脉注射Gd - DTPA仅在特定病例中有用。